Haemonetics Expands Heart Surgery Arsenal With Vivasure Acquisition - Haemonetics (NYSE:HAE)

Haemonetics Expands Heart Surgery Arsenal With Vivasure Acquisition - Haemonetics (NYSE:HAE)

Haemonetics (HAE) to acquire Vivasure Medical Limited for 100 million euros upfront plus potential milestone payments.

Haemonetics acquires vessel closure specialist Vivasure Medical

PerQseal Haemonetics Corporation today announced the acquisition of Vivasure Medical, a Galway, Ireland-based company developing next-generation technology for percutaneous vessel closure. Vivasure’s PerQseal Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26Fr) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and endovascular procedures. In 2…

Galways's Vivasure Medical acquired for up to €185m

Vivasure Medical, the Galway-based medical device company, has been acquired by the NYSE-listed Haemonetics Corporation in a deal worth up to €185m if certain conditions are met. Vivasure develops advanced polymer implants and delivery systems, primarily focused on minimally invasive vessel closure in cardiology, interventional radiology and vascular surgery. Haemonetics made a strategic investment in Vivasure in 2022 and held an option to acqui…

Haemonetics Expands Heart Surgery Arsenal With Vivasure Acquisition

Haemonetics Corporation (NYSE:HAE) on Friday said it will acquire Ireland-based Vivasure Medical Limited, a move aimed at strengthening its position …

Vivasure Medical Announces Acquisition by Haemonetics ...

Haemonetics Acquires Vivasure Medical Limited

Open the article to view the coverage from The AI Journal